Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.81)
# 1,914
Out of 5,008 analysts
26
Total ratings
62.5%
Success rate
18.79%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $453.28 | -24.11% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $17.05 | +213.78% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $36.76 | +8.81% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $22.86 | +31.23% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.20 | +63.46% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $14.53 | +10.12% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.74 | +38,986.16% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $2.50 | +18,300.00% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.20 | +1,493.75% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $15.90 | +0.63% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $4.87 | +824.02% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $453.28
Upside: -24.11%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $17.05
Upside: +213.78%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $36.76
Upside: +8.81%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $22.86
Upside: +31.23%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.20
Upside: +63.46%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $14.53
Upside: +10.12%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.74
Upside: +38,986.16%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $2.50
Upside: +18,300.00%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.20
Upside: +1,493.75%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $15.90
Upside: +0.63%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $4.87
Upside: +824.02%